RE: Poolbeg Pharma CEO to be joined by David English, VP, Biz Dev at our 28 Feb webinar1 Mar 2023 17:56
They are certainly focusing on 001 as they seem confident that it will be a potential blockbuster for the company caterpulting us to a different level. AI seems to excite them alot. Is it because of interest shown for the data that comes out from one three and Cytoreason. Is this for some sort of partnership or individual products that will be pinpointed,I don't know.
Wouldn't it be nice to see a bidding war.